Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Clinical Pharmacology & Biopharmaceutics, is a peer reviewed journal provides the rapid publication of articles in all areas related to pharmaceutics, applied biopharmaceutics, pharmacology, clinical drug trials, pharmacokinetics, pharmacodynamics, pharmacogenetics, pharmacogenomics, pharmaceutical formulation, toxicology etc.
Clinical Pharmacology & Biopharmaceutics welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).The disease was first identified in 2019 in Wuhan, the capital of China's Hubei province, and has since spread globally, resulting in the ongoing 2019–20 coronavirus pandemic.
There is no vaccine or specific antiviral treatment for COVID-19. The World Health Organization (WHO) declared the 2019–20 coronavirus outbreak a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 and a pandemic on 11 March 2020.
Proposals are invited from all recognised experts in this area for creating special issues that fall within the scope of Omics Journal of Clinical Pharmacology & Biopharmaceutics. Special issues should focus on "Clinical aspects of COVID-19 vaccines". The aim of these special issues is to broaden the scope of Omics journals by encouraging publication of articles specific to high profile research topics from all areas of Pharma and COVID-19.
Special issues will be released on a monthly basis and proposals will be accepted accordingly. All proposals should include the following information:
For any queries, WhatsApp us at: +44-1474556909.
Review the special issue proposals for relevance to current research in the concerned field.
Recommend suitable proposals and their guest editors along with their biographies.
Once a proposal has been accepted by the EB members for creating a special issue, the corresponding guest editors will be responsible for handling and processing of the special issue articles.
State the importance of the proposed special issue theme and explain how the special issue articles will contribute towards advancing the scope of the journal.
Suggest potential authors and invite them for contributing relevant articles for the proposed special issue.
Suggest a minimum of 3-5 reviewers for the manuscripts submitted towards the special issue.
Carry out all communications with potential authors and reviewers concerning author guidelines for manuscript preparation and reviewing.
Prepare a timeline and schedule for the release of special issue articles.
This should include a timeline for manuscript preparation, review process, and final submission.
Oversee the submission of final edited versions of the contributing articles along with the contact information of all corresponding authors.
Include a short editorial for the topic of interest written either by the guest editor or by any of the contributors.
Special issue articles can include both original unpublished research articles and review articles related to the specific theme.
Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee [selected by the guest editor(s)].
All the articles in special issues should strictly adhere to journal style and formatting.
Each special issue can be created with 10-15 articles.
Submission should be accompanied by a cover letter with reference to the concerned special issue theme.
Accepted manuscripts submitted before the deadline will be published within the given timeframe for the respective journal publication.
Once accepted and published, all special issues will be released under an open access system and will be freely available for reading, downloading, and printing.
For further information on special issue guidelines and submission process, please contact [email protected]
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals